Biotech, Food & Drug

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Oct
13
2013
Federal Energy Regulatory Commission (FERC) Delays Electric Quarterly Reports (EQRs) Filing Deadline Bracewell LLP
Oct
12
2013
Federal Financial Institutions Examination Council (FFIEC) Warns on Windows XP Katten
Oct
11
2013
Federal Court Rules Maryland Scheme to Promote Investment in In-State Generation Unconstitutional McDermott Will & Emery
Oct
10
2013
More Michigan Wind Farms to Commence Construction in 2013 Varnum LLP
Oct
10
2013
Texas Regulators Take First Steps to Acquire Greenhouse Gas Permitting Authority Bracewell LLP
Oct
10
2013
Massachusetts Department of Energy Resources (DOER) Finalizes Rules for Solar Carve-Out Program McDermott Will & Emery
Oct
9
2013
Cloning Decision Could Lead to Copycat Litigation in the World of Racing Sheppard, Mullin, Richter & Hampton LLP
Oct
9
2013
Judge Jones Certifies Class Action In Southwest Virginia Natural Gas Case Womble Bond Dickinson (US) LLP
Oct
8
2013
Environmental Protection Agency (EPA) Proposes Carbon Emissions Rules for New Power Plants Godfrey & Kahn S.C.
Oct
8
2013
Energy and Environmental Law Update - Week of October 7, 2013 Mintz
Oct
8
2013
Getting it Right the First Time: Food and Drug Administration's (FDA) New Draft Guidance on Abbrievated New Drug Applications (ANDA) Submissions and Refuse-to-Receive Standards Michael Best & Friedrich LLP
Oct
8
2013
Governor Brown Signs Senate Bill 4 Regulating Hydraulic Fracturing Well Stimulation Treatments Sheppard, Mullin, Richter & Hampton LLP
Oct
7
2013
Congress Passes Two Hydropower Bills During a Summer of Gridlock Mintz
Oct
7
2013
California Passes Landmark Green Chemical Laws Sheppard, Mullin, Richter & Hampton LLP
Oct
7
2013
Department of Energy Advanced Research Projects Agency-Energy (ARPA-E) Will Exercise Its Authority to Issue Small Business Innovation Research (SBIR) Grants to Venture Capital Majority-Owned Small Businesses Mintz
Oct
7
2013
New Colorado Microgrid Closer to Reality: Niobrara NatGas LLC Receives Certificate of Public Convenience and Necessity (CPCN) – First New Colorado Natural Gas LDC Since 1997 Lewis Roca Rothgerber LLP
Oct
7
2013
Power Plant Cases in the Supreme Court McDermott Will & Emery
Oct
7
2013
Michigan Adopt-A-Watt Helps Library Varnum LLP
Oct
6
2013
Climate Change Report Causes Alarm Risk and Insurance Management Society, Inc. (RIMS)
Oct
6
2013
Public Hearing to Examine Need for New Environmental Bond Act In New York Greenberg Traurig, LLP
Oct
5
2013
Food and Drug Administration (FDA) Finalizes Guidance on Mobile Medical Apps Barnes & Thornburg LLP
Oct
4
2013
Solar Energy Industries Association Proposes Compromise Plan for U.S. - China Solar Conflict McDermott Will & Emery
Oct
4
2013
Government Shutdown – Implications for Government Environmental Programs and Activities Beveridge & Diamond PC
Oct
4
2013
Utilizing Renewable Energy Tax Incentives to Make Your Tribal Energy Projects a Reality Godfrey & Kahn S.C.
Oct
3
2013
The Food and Drug Administration (FDA) Releases Long-Awaited Final Guidance on Mobile Medical Applications Sheppard, Mullin, Richter & Hampton LLP
Oct
3
2013
What the Strong Initial Public Offering (IPO) Market Means for Emerging Energy and Renewable Technology Companies Mintz
Oct
3
2013
Department of Energy Authorizes Fourth Liquefied Natural Gas (LNG) Facility to Export to Non-Free-Trade Agreement Countries ArentFox Schiff LLP
Oct
3
2013
Skinmedica, Inc. and, i.e., Disclaimer Re: Patent Litigation Schwegman, Lundberg & Woessner, P.A.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins